These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698 [TBL] [Abstract][Full Text] [Related]
4. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease. Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905 [TBL] [Abstract][Full Text] [Related]
7. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits-Filho R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283 [TBL] [Abstract][Full Text] [Related]
8. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Mc Causland FR; Claggett B; Burdmann EA; Eckardt KU; Kewalramani R; Levey AS; McMurray JJ; Parfrey P; Remuzzi G; Singh AK; Solomon SD; Toto RD; Pfeffer MA Am J Kidney Dis; 2016 Dec; 68(6):873-881. PubMed ID: 27646425 [TBL] [Abstract][Full Text] [Related]
9. α Maraj M; Hetwer P; Kuśnierz-Cabala B; Maziarz B; Dumnicka P; Kuźniewski M; Ceranowicz P Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835927 [TBL] [Abstract][Full Text] [Related]
10. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease. Yang FJ; Hsieh CY; Shu KH; Chen IY; Pan SY; Chuang YF; Chiu YL; Yang WS Sci Rep; 2020 Apr; 10(1):5988. PubMed ID: 32249825 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure. Ocak N; Dirican M; Ersoy A; Sarandol E Ren Fail; 2016 Nov; 38(10):1639-1646. PubMed ID: 27764985 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology? Millet C; Bosson JL; Pernod G; Wauters JP; Couturier P; Quesada JL; Zaoui P Aging Clin Exp Res; 2011; 23(5-6):357-63. PubMed ID: 22526070 [TBL] [Abstract][Full Text] [Related]
13. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients. Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040 [TBL] [Abstract][Full Text] [Related]
14. Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease. Kotani K; Kimura S; Gugliucci A J Physiol Biochem; 2011 Sep; 67(3):437-41. PubMed ID: 21484479 [TBL] [Abstract][Full Text] [Related]
15. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study. Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072 [TBL] [Abstract][Full Text] [Related]
16. Changes of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum Hs-CRP and myeloperoxidase. Borato DC; Parabocz GC; Ribas SR; Kalva-Filho CA; Borba LM; Ito CA; Bail L; dos Santos FA; Vellosa JC Metabolism; 2012 Oct; 61(10):1353-60. PubMed ID: 22480983 [TBL] [Abstract][Full Text] [Related]
17. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis. Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711 [TBL] [Abstract][Full Text] [Related]
18. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study. Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients. Gluba-Brzozka A; Franczyk B; Bartnicki P; Rysz-Gorzyn Ska M; Rysz J Curr Vasc Pharmacol; 2017; 15(2):123-134. PubMed ID: 27774887 [TBL] [Abstract][Full Text] [Related]